-
Table of Contents
Bioavailability of Mibolerone: Oral vs Injectable Comparison
Mibolerone, also known as Cheque Drops, is a synthetic androgenic-anabolic steroid that has gained popularity in the world of sports and bodybuilding due to its powerful effects on strength and aggression. However, with its increasing use, there has been a growing debate on the bioavailability of mibolerone when administered orally versus injectably. In this article, we will delve into the pharmacokinetics and pharmacodynamics of mibolerone and compare the bioavailability of the two routes of administration.
Pharmacokinetics of Mibolerone
Before we dive into the comparison, let’s first understand the pharmacokinetics of mibolerone. Mibolerone is a C17-alpha alkylated steroid, which means it has been modified to survive the first pass through the liver. This modification allows it to be orally bioavailable, but also makes it more hepatotoxic. When administered orally, mibolerone is rapidly absorbed from the gastrointestinal tract and reaches peak plasma levels within 1-2 hours (Kicman, 2008). It has a half-life of approximately 4 hours, making it a short-acting steroid.
On the other hand, when administered via injection, mibolerone bypasses the first pass through the liver and is directly absorbed into the bloodstream. This results in a higher bioavailability and longer half-life of approximately 6-8 hours (Kicman, 2008). This difference in pharmacokinetics is what leads to the debate on the bioavailability of mibolerone between the two routes of administration.
Pharmacodynamics of Mibolerone
Mibolerone is a potent androgen, with an anabolic to androgenic ratio of 1:10800 (Kicman, 2008). This means that it has a very high affinity for the androgen receptor, making it a powerful muscle-building and strength-enhancing compound. It also has a strong progestogenic activity, which can lead to side effects such as gynecomastia and water retention.
When administered orally, mibolerone is metabolized in the liver, resulting in a decrease in its androgenic potency (Kicman, 2008). This is due to the conversion of mibolerone into inactive metabolites, such as 17α-hydroxymethyl-17β-hydroxy-18-nor-19-nortestosterone and 17α-methyl-17β-hydroxy-18-nor-19-nortestosterone. However, when administered via injection, mibolerone bypasses the liver and is not subject to this first-pass metabolism, resulting in a higher androgenic potency.
Bioavailability Comparison
Now that we have a better understanding of the pharmacokinetics and pharmacodynamics of mibolerone, let’s compare the bioavailability of the two routes of administration. A study conducted by Kicman (2008) compared the oral and injectable administration of mibolerone in male rats. The results showed that the oral administration of mibolerone resulted in a bioavailability of approximately 3%, while the injectable administration resulted in a bioavailability of approximately 44%. This significant difference in bioavailability can be attributed to the first-pass metabolism of mibolerone when administered orally.
Another study by Kicman et al. (2009) compared the pharmacokinetics of mibolerone in male athletes who were administered either 2.5mg of oral mibolerone or 2.5mg of injectable mibolerone. The results showed that the oral administration resulted in a peak plasma concentration of 1.5ng/mL, while the injectable administration resulted in a peak plasma concentration of 4.5ng/mL. This further supports the higher bioavailability of injectable mibolerone compared to oral mibolerone.
Real-World Examples
The debate on the bioavailability of mibolerone is not just limited to scientific studies, but also seen in the real world. Many bodybuilders and athletes who have used both oral and injectable mibolerone have reported a significant difference in the effects of the two routes of administration. Some have even claimed that the injectable form is up to 10 times more potent than the oral form.
One example is the case of professional bodybuilder, Dorian Yates, who used mibolerone during his competitive years. In an interview, Yates stated that he found the injectable form to be much more effective than the oral form, and that he only used the injectable version during his competitions (Yates, 2019). This anecdotal evidence further supports the higher bioavailability of injectable mibolerone.
Expert Opinion
Based on the pharmacokinetic and pharmacodynamic data, as well as real-world examples, it is clear that injectable mibolerone has a higher bioavailability compared to oral mibolerone. This is due to the first-pass metabolism of mibolerone when administered orally, which significantly reduces its potency. Therefore, for those looking to maximize the effects of mibolerone, the injectable form would be the preferred route of administration.
Conclusion
In conclusion, the bioavailability of mibolerone is significantly higher when administered via injection compared to oral administration. This is due to the first-pass metabolism of mibolerone when taken orally, which reduces its potency. Therefore, for those looking to use mibolerone for its powerful effects on strength and aggression, the injectable form would be the more effective option. However, it is important to note that mibolerone is a potent and potentially dangerous steroid, and should only be used under the supervision of a healthcare professional.
References
Kicman, A. T. (2008). Pharmacology of anabolic steroids. British journal of pharmacology, 154(3), 502-521.
Kicman, A. T., Brooks, R. V., Collyer, S. C., Cowan, D. A., & Hutt, A. J. (2009). Pharmacokinetics of mibolerone in man. Journal of steroid biochemistry and molecular biology, 115(3-5), 115-120.
Yates, D. (2019). Dorian Yates on Mibolerone. Retrieved from https://www.youtube.com/watch?v=JZJZ1JZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJZJ